HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coupon Accounting Adjustment Revenue Impact Cited To Analysts

This article was originally published in The Rose Sheet

Executive Summary

Pharmaceutical and consumer products firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.

You may also be interested in...



J&J Consumer Sales Impact Of $650 Mil. Expected With Accounting Changes

Pending accounting changes related to spending on couponing and sales promotion at the retail level will reduce Johnson & Johnson's reported consumer sales by $650 mil. in 2002, the firm said during an Oct. 16 analyst call.

J&J Consumer Sales Impact Of $650 Mil. Expected With Accounting Changes

Pending accounting changes related to spending on couponing and sales promotion at the retail level will reduce Johnson & Johnson's reported consumer sales by $650 mil. in 2002, the firm said during an Oct. 16 analyst call.

Gillette

Revised net sales in 1999 and 2000 down nearly 1% to $9.07 bil. and $9.23 bil., respectively, due to changes made to comply with findings of Emerging Issues Task Force of Financial Accounting Standards Board. New accounting procedures change the way some companies account for coupons, rebates and other incentives in income statements (1"The Rose Sheet" Feb. 12, p. 15). For Gillette, sales promotion and advertising under "selected" selling, general and administrative expenses will be reduced. Gillette originally reported sales of $9.3 bil. for 2000 (2"The Rose Sheet" Jan. 29, p. 7)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel